Part 1 and 2: PharmaDrug CEO Daniel Cohen On Johns Hopkins University Partnership To Evaluate DMT Aug 27, 2021
PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative… Aug 25, 2021
Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its DMT and 5-MeO-DMT Inspired… Aug 24, 2021
PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated… Aug 16, 2021
Mindset Pharma Announces Preclinical Results Demonstrating Superior Efficacy, Safety and Shorter Duration of Action… Aug 10, 2021